Contact us

877-469-1TRM
424-208-8866

A Phase II Randomized Open Label Study of MM-121 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Platinum Resistant/Refractory Advanced Ovarian Cancers

For additional information, visit ClinicalTrials.gov or contact your Site Relationship Manager.

Patient Population Investigational Product(s) Phase Status
Ovarian MM-121 II Closed to Accrual